1. |
Flameng W, Jashari R, De Visscher G, et al. Calcifcation of allograf and stentless xenograft valves for right ventricular outflow tract reconstruction:an experimental study in adolescent sheep. J Torac Cardiovasc Surg, 2011, 141(6):1513-1521.
|
2. |
Burch PT, Kaza AK, Lambert LM, et al. Clinical performance of decellularized cryopreserved valved allografts compared with standard allografts in the right ventricular outflow tract. Ann Torac Surg, 2010, 90(4):1301-1305.
|
3. |
Cebotari S, Tudorache I, Ciubotaru A, et al.Use of fresh decellularized allografts for pulmonary valve replacement may reduce the reoperation rate in children and young adults:early report. Circulation, 2011, 124(11 Suppl):S115-S123.
|
4. |
崔彬, 刘迎龙.同种组织瓣移植后免疫排斥反应及其对策.中华胸心血管外科杂志, 2003, 19(5):312-314.
|
5. |
Wilhelmi MH, Mertsching H, Wilhelmi M, et al. Role of inflamma-tion in allogeneic and xenogeneic heart valve degeneration:immunohistochemical evaluation of inflammatory endothelial cell activation. J Heart Valve Disease, 2003, 12(6):520-526.
|
6. |
崔彬, 刘迎龙, 谢宁, 等.去细胞组织工程同种心脏瓣膜的构建.中华医学杂志, 2004, 84(16):1354-1357.
|
7. |
Bechtel JF, Marquardt A, Müller-Steinhardt M, et al. Anti-HLA antibodies and pulmonary valve allograft function after the Ross procedure. J Heart Valve Disease, 2009, 18(6):673-680.
|
8. |
Kneib C, von Glehn CQ, Costa FD, et al. Evaluation of humoral immune response to donor HLA afer implantation of cellularized versus decellularized human heart valve allografs. Tissue Antigens, 2012, 80(2):165-174.
|
9. |
Batten P, McCormack AM, Rose ML, et al. Valve interstitial cells induce donor-specific T-cell anergy. J Thorac Cardiovasc Surg, 2001, 122(1):129-135.
|
10. |
于建华, 郭宏伟, 刘美明, 等.液氮冻存人同种心脏瓣膜、大动脉免疫原性的对比研究.中华医学杂志, 2009, 89(31):2225-2228.
|
11. |
Dignan R, O'Brien M, Hogan P, et al. Aortic valve allograf structural deterioration is associated with a subset of antibodies to human leukocyte antigens. J Heart Valve Disease, 2003, 12(3):382-390.
|
12. |
Brockbank KG, Song YC. Mechanisms of bioprosthetic heart valve calcifcation. Transplantation, 2003, 75(8):1133-1135.
|
13. |
Flameng W, De Visscher G, Mesure L, et al. Coating with fbronectin and stromal cell-derived factor-1αof decellularized homografs used for right ventricular outflow tract reconstruction eliminates immune response-related degeneration. J Torac Cardiovasc Surg, 2014, 147(4):1398-1404.
|
14. |
Brown JW, Ruzmetov M, Eltayeb O, et al. Performance of SynerGraf decellularized pulmonary homograf in patients undergoing a Ross procedure. Ann Torac Surg, 2011, 91(2):416-422.
|
15. |
Ronald CE, Patti ED, Steven G, et al. Decellularized human valve allografs. Ann Torac Surg, 2001, 71(5 Suppl):S428-S432.
|
16. |
Hopkins RA, Jones AL, Wolfinbarger L, et al. Decellularization reduces calcification while improving both durability and 1-year functional results of pulmonary homograf valves in juvenile sheep. J Torac Cardiovasc Surg, 2009, 37(4):907-913.
|
17. |
Hopkins RA. Tissue engineering of heart valves:decellularized valve scaffolds. Circulation, 2005, 111(21):712-714.
|
18. |
Ruzmetov M, Shah JJ, Geiss DM, et al. Decellularized versus standard cryopreserved valve allografs for right ventricular outflow tract reconstruction:a single-institution comparison. J Thorac Cardiovasc Surg, 2012, 143(3):543-549.
|
19. |
Quinn RW, Hilbert SL, Bert AA, et al. Performance and morphology of decellularized pulmonary valves implanted in juvenile sheep. Ann Torac Surg, 2011, 92(1):131-137.
|
20. |
Dainese L, Guarino A, Burba I, et al. Heart valve engineering:decellularized aortic homograf seeded with human cardiac stromal cells. J Heart Valve Dis, 2012, 21(1):125-134.
|